Siglec-2 and Siglec-10 appear to be involved in B cell tolerance acting as immunosuppressive receptors that specifically counteract B cell receptor (BCR) signaling (47) and B cell proliferation in lymphoma (48). The gene discussed is BCR; the disease is lymphoma.